Neko Health raises $700 million as CEO claims clinic-level profit
The body-scanning startup says it has 100,000 members, but did not disclose revenue, valuation or headcount in the reported update.
By Ingrid Halvorsen · Venture Capital Reporter
· 2 min read
Neko Health has raised $700 million in Series C funding, Sifted reported, giving the Stockholm body-scanning startup one of the larger late-stage financings in European healthtech. CEO Hjalmar Nilsonne told Sifted that the company now has 100,000 members and is profitable at the clinic level.
The company offers body scans through physical clinics, placing it in the capital-intensive part of preventive health rather than the software-only side of digital health. Sifted interviewed Nilsonne at Neko’s Stockholm clinic, described as the company’s refurbished first clinic.
Neko did not disclose revenue, valuation, headcount or the terms of the Series C in the reported details. The company also did not break out how many of its 100,000 members are active, how many have completed repeat scans, or how member growth maps to clinic capacity.
The clinic-level profitability claim is narrower than companywide profitability. It indicates, according to Nilsonne’s statement, that individual sites can operate profitably, but it does not establish whether the whole company is profitable after central costs such as product development, regulatory work, corporate overhead and expansion. Neko did not provide a detailed definition of the metric in the reported remarks.
That distinction matters for the category. Body-scanning businesses have to combine hardware, clinical staffing, real estate and consumer acquisition, which makes their economics different from pure software healthcare companies. A high member count can show demand, but utilization, pricing, repeat visits and clinician time determine whether the model scales cleanly.
The Series C follows earlier funding rounds implied by the company’s progression to a late-stage financing, but the reported update centered on the new $700 million raise, the 100,000-member figure and the clinic-level profitability claim. Without disclosed revenue or valuation, it is not possible to assess the multiple investors paid or how much the round changes Neko’s ownership structure.
For Neko, the financing gives it more capital to expand a clinic-based preventive health model that has drawn investor attention despite the operational complexity. The open question is whether the company can extend site-level profitability across a broader network without losing the economics Nilsonne is now citing.
This story draws on original reporting from Sifted.
